ISSN:
1573-904X
Keywords:
Tacrine
;
microdialysis
;
blood–brain barrier
Source:
Springer Online Journal Archives 1860-2000
Topics:
Chemistry and Pharmacology
Notes:
Abstract Microdialysis was used to sample simultaneously the distribution of THA (9-amino-l,2,3,4-tetrahydroacridine; Tacrine), a potential anti-Alzheimer agent, both in blood and across the blood–brain barrier of anesthetized and awake, freely moving rats. Microdialysis probes were implanted in the jugular vein and dorsal hippocampus and dialysis samples were simultaneously collected from both sites. Dialysis samples were analyzed using a microbore column chromato-graphic assay with a detection limit of 0.3 ng/ml. Pharmacokinetic parameters were calculated after a 1 mg/kg intravenous dose of THA. Plasma pharmacokinetics followed a biexponential mode, with t 1/2(dis.) = 8.4 ± 2.7 min and t 1/2(elim.) = 76.7 ± 24.2 min for awake, freely moving rats. THA rapidly penetrated the blood–brain barrier, with maximum concentrations attained within 60 min post-dose. In the brain of awake, freely moving rats t 1/2(abs.) was 26.0 ± 5.2 min and t 1/2(elim.) was 99.1 ± 17.7 min. THA levels in hippocampus extracellular fluid were 10 times lower than those in plasma. For anesthetized rats, the t l/2(elim.) in blood was 154.8 ± 46.8 min, while in the hippocampus t 1/2(elim.) was 159.5 ± 31.7 min. The binding of THA in rat plasma was 56.2 ± 5.0%, while the fraction bound to rat whole blood was 73.3 ± 4.1% as determined by microdialysis and ultrafiltration.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1023/A:1018964727833
Permalink